Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Bad
|
Filing tables
Filing exhibits
TRIL similar filings
Filing view
External links
Exhibit 99.8
Consent of Independent Registered Public Accounting Firm
We consent to the use in the Annual Report on Form 40-F and to the incorporation by reference in the Registration Statement on Form F-10 (File No. 333- 222085) of Trillium Therapeutics Inc., of our report dated March 8, 2018, with respect to the consolidated financial statements of Trillium Therapeutics Inc. as at and for the years ended December 31, 2017 and 2016.
/s/ Ernst & Young LLP | |
Toronto, Canada | Chartered Professional Accountants |
March 8, 2018 | Licensed Public Accountants |